CS logo
small CS logo
Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques

Marseille, France
Hôpital à Marseille

About Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques


L'hôpital nord de Marseille est l'un des principaux hôpitaux de la ville. Il est situé dans le quartier de Notre-Dame-Limite, dans le 15ᵉ arrondissement. L'hôpital fait partie de l'Assistance publique - Hôpitaux de Marseille. L'hôpital construit par René Egger est inauguré en 1964.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Intergroupe Francophone de Cancerologie Thoracique
6
Hoffmann-La Roche
3
Pfizer
2
Total Rows: 3

Clinical Trials at Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques


During the past decade, Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1122Started TrialsCompleted Trails20170123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy
2007-09-01
2014-11-01
Terminated
88
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2010-01-01
2015-12-01
Completed
1,069
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
2011-01-13
2016-11-30
Completed
343
A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
2011-06-25
2016-06-25
Completed
485
French Biological Observatory on Lung Cancer in Never Smokers
2011-11-01
2013-01-01
Completed
422
Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR
2012-05-15
2020-06-17
Completed
379
Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer
2012-07-01
2017-11-30
Completed
932
Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.
2012-12-01
2017-10-01
Completed
120

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsIntergroupeFrancophone deCancerologieThoracique: 6IntergroupeFrancophone deCancerologieThoracique: 6Hoffmann-La Roche: 3Hoffmann-La Roche: 3Pfizer: 2Pfizer: 2

Created with Highcharts 11.1.0Top CollaboratorsGroupe Francais DePneumo-Cancerologie:1Groupe Francais DePneumo-Cancerologie:1

Clinical Trials Conditions at Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques


According to Clinical.Site data, the most researched conditions in "Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Non-Squamous Non-Small Cell Lung Cancer" (2 trials), "Advanced Non Small Cell Lung Cancer" (1 trials), "Cancer" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques" in a lesser frequency.

Clinical Trials Intervention Types at Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques


Most popular intervention types in "Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Pemetrexed" (4 trials), "Atezolizumab" (2 trials), "Bevacizumab" (2 trials), "Cisplatin" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques


The vast majority of trials in "Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques" are 10 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques


Currently, there are NaN active trials in "Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 2: 3Phase 2: 3Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Active, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1